Israel Englander Gain Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 23,373 shares of GANX stock, worth $33,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,373
Previous 44,416
47.38%
Holding current value
$33,423
Previous $167,000
82.63%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GANX
# of Institutions
31Shares Held
3.75MCall Options Held
0Put Options Held
0-
Timelo Investment Management Inc.605KShares$865,5610.45% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$841,4260.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$809,5650.04% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL450KShares$643,5000.0% of portfolio
-
Hohimer Wealth Management, LLC330KShares$471,9000.1% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $17M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...